SPONSOR
St. Jude Children's Research Hospital
Total Trials
12
Recruiting
12
Phases
Phase 2, Phase 1, Phase 1, Phase 2
Conditions studied: Neuroblastoma RecurrentMedulloblastomaGastro-Intestinal DisorderHemoglobinopathiesMuscle WeaknessLow Muscle MassSarcopeniaAcute Lymphoblastic LeukemiaObesityAcute Pancreatitis
St. Jude Children's Research Hospital is a clinical research sponsor with 12 registered studies on ClinicalTrials.gov, of which 12 are actively recruiting participants. Research covers conditions including Neuroblastoma Recurrent, Medulloblastoma, Gastro-Intestinal Disorder, Hemoglobinopathies.
The trial portfolio spans Phase 2, Phase 1, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — St. Jude Children's Research Hospital
How many clinical trials has St. Jude Children's Research Hospital sponsored?
ClinicalMetric currently tracks 12 clinical trials sponsored by St. Jude Children's Research Hospital, of which 12 are actively recruiting participants. These trials cover conditions including Neuroblastoma Recurrent, Medulloblastoma, Gastro-Intestinal Disorder. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does St. Jude Children's Research Hospital research focus on?
St. Jude Children's Research Hospital clinical trials span Neuroblastoma Recurrent, Medulloblastoma, Gastro-Intestinal Disorder, Hemoglobinopathies, Muscle Weakness, and additional conditions. The research pipeline includes Phase 2, Phase 1, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a St. Jude Children's Research Hospital clinical trial?
To participate in a St. Jude Children's Research Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all St. Jude Children's Research Hospital trials with current recruitment status updated daily.
Clinical Trials by St. Jude Children's Research Hospital
NCT07085338 Phase 2
Recruiting
A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory Neuroblastoma
Neuroblastoma Recurrent
NCT05535166 Phase 2
Recruiting
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
Medulloblastoma
NCT05664113 Phase 1
Recruiting
Feasibility, Safety, and Potential Efficacy of Fecal Microbiota Transplantation (FMT) for Gastrointestinal Dysfunction in Children Following Hematopoietic Cell Transplant (HCT).
Gastro-Intestinal Disorder
NCT04671212
Recruiting
Discarded Bone Marrow for Hematology Research
Hemoglobinopathies
NCT07531498
Recruiting
Muscle Aging Phenotypes in Childhood Cancer Survivors
Muscle Weakness
NCT07228741 Phase 2
Recruiting
Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With Obesity
Acute Lymphoblastic Leukemia
NCT04195347 Phase 1, Phase 2
Recruiting
Study of CM4620 to Reduce the Severity of Pancreatitis Due to Asparaginase
Acute Pancreatitis
NCT07444216
Recruiting
A Longitudinal Photo-Narrative Exploration of Hope During Phase 1/2 Clinical Trials For Pediatric Cancer
Cancer, Therapy-Related
NCT02720679
Recruiting
Investigation of the Genetics of Hematologic Diseases
Bone Marrow Failure Syndromes
NCT00700414
Recruiting
International Pediatric Adrenocortical Tumor Registry
Adrenocortical Tumor
NCT04558736 Phase 2
Recruiting
Haploidentical HCT for Severe Aplastic Anemia
Aplastic Anemia
NCT06847269 Phase 2
Recruiting
CAR T CELL Therapy for Pediatric, Adolescent and Young Adult Patients With CD19-Positive Leukemia
Acute Lymphoblastic Leukemia
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology